Alternative immunosuppression for acute renal failure in liver transplantation: role of ultra-low dose tacrolimus and basiliximab.
Varo
E
E
Transplantation Unit, Hospital Clinico Universitario, 15706 Santiago de Compostela, Spain.
Lopez
A
A
Castroagudin
J F
JF
Delgado
M
M
Conde
R
R
Ferrer
E
E
Otero
E
E
Tomé
S
S
Bustamante
M
M
Rivero
C
C
Martinez
J
J
Mariño
A
A
D000293:Adolescent; D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000077552:Basiliximab; D002648:Child; D002675:Child, Preschool; D003404:Creatinine / Q000097:blood; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007677:Kidney Function Tests; D017114:Liver Failure, Acute / Q000276:immunology*; D016031:Liver Transplantation / Q000009:adverse effects / Q000276:immunology*; D008875:Middle Aged; D011183:Postoperative Complications / Q000276:immunology*; D011993:Recombinant Fusion Proteins; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D000077552:Basiliximab; D003404:Creatinine; D016559:Tacrolimus